If you are on medication for osteoporosis, are you ever tempted to stop taking it? If your answer is yes, you are not alone. Studies indicate that especially for those […]

SECONDARY OSTEOPOROSIS Medications and medical conditions can increase the risk of osteoporosis and osteoporotic fractures. Drugs and Diseases that can Cause Bone Loss, Falls and/or Fractures There are several well […]

The Osteoporosis Exemplary Care Program (OECP) at St. Michael’s Hospital in Toronto, Ontario has been a leader in the FLS movement in Canada and worldwide. OECP was founded in 2002 […]

The B.C. Ministry of Health is conducting a survey of patients, caregivers, and advocacy groups to achieve input regarding osteoporosis therapies in British Columbia and B.C. PharmaCare coverage. We know […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

HORMONE THERAPY (HT) Estrogen plays such an important role in maintaining bone. Hormone Therapy (HT) or estrogen/progesterone, is commonly used to relieve the symptoms of menopause. However, because estrogen plays […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

SERMS Selective Estrogen Receptor Modulators Raloxifene (Evista®) is from a family of drugs called SERMs (Selective Estrogen Receptor Modulators). How Does Raloxifene Work? During their reproductive years, women produce significant […]